AR020250A1 - Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion - Google Patents

Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Info

Publication number
AR020250A1
AR020250A1 ARP990104229A ARP990104229A AR020250A1 AR 020250 A1 AR020250 A1 AR 020250A1 AR P990104229 A ARP990104229 A AR P990104229A AR P990104229 A ARP990104229 A AR P990104229A AR 020250 A1 AR020250 A1 AR 020250A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
alkyl
optionally substituted
ring
halo
Prior art date
Application number
ARP990104229A
Other languages
English (en)
Spanish (es)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR020250A1 publication Critical patent/AR020250A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990104229A 1998-08-24 1999-08-24 Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion AR020250A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9757498P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
AR020250A1 true AR020250A1 (es) 2002-05-02

Family

ID=22264103

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104229A AR020250A1 (es) 1998-08-24 1999-08-24 Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Country Status (22)

Country Link
EP (1) EP1107756A4 (pt)
JP (1) JP2002523369A (pt)
KR (1) KR20010072945A (pt)
CN (1) CN1314813A (pt)
AR (1) AR020250A1 (pt)
AU (1) AU748750B2 (pt)
BR (1) BR9913225A (pt)
CA (1) CA2341271A1 (pt)
CO (1) CO5160266A1 (pt)
CZ (1) CZ2001669A3 (pt)
HU (1) HUP0103433A3 (pt)
ID (1) ID27690A (pt)
IL (1) IL141542A0 (pt)
NO (1) NO20010916L (pt)
NZ (1) NZ509867A (pt)
PE (1) PE20001063A1 (pt)
PL (1) PL346267A1 (pt)
TR (1) TR200100672T2 (pt)
TW (1) TW572757B (pt)
UY (1) UY25677A1 (pt)
WO (1) WO2000010566A1 (pt)
ZA (1) ZA200101505B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465456B2 (en) * 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
JP2002020366A (ja) * 2000-07-05 2002-01-23 Sumitomo Seika Chem Co Ltd アルキルチオフェニル酢酸類の製造方法
PE20020689A1 (es) 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
PE20030044A1 (es) * 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
US6861433B2 (en) 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
ES2256331T3 (es) 2000-12-21 2006-07-16 PHARMACIA & UPJOHN COMPANY LLC Derivados de quinolina antimicrobianos y uso de los mismos para tratar infecciones bacterianas.
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7105547B2 (en) 2002-10-10 2006-09-12 Pharmacia And Upjohn Company Antimicrobial 1-aryl dihydropyridone compounds
MXPA05007724A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
MXPA05011654A (es) 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
EP2492264A3 (en) 2003-06-03 2012-12-19 Rib-X Pharmaceuticals, Inc. Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
JP2007525468A (ja) * 2003-06-03 2007-09-06 リブ−エックス ファーマシューティカルズ,インコーポレイテッド スルホンアミド化合物ならびにその製造方法および使用方法
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US20070197541A1 (en) * 2003-07-29 2007-08-23 Oyelere Adegboyega K Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
TW200526649A (en) 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CN1898238A (zh) 2003-12-18 2007-01-17 莫弗凯姆联合化学股份公司 噁唑烷酮-喹诺酮杂化物抗生素
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス,インコーポレイテッド トリアゾール類の合成方法
AT503354B1 (de) * 2006-02-22 2008-07-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von 3,4-disubstituierten phenylessigsäuren, sowie neue zwischenverbindungen
JP4518066B2 (ja) * 2006-10-25 2010-08-04 宇部興産株式会社 ジアルコキシニトリル誘導体及びその製法
CN110423610B (zh) * 2019-08-29 2023-05-12 浙江理工大学 一种检测双光子汞离子荧光探针及其制备方法与使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2045049A1 (de) * 1970-09-11 1972-03-23 Dr Karl Thomae GmbH, 7950 Biberach Neue Nitrofurandenvate und Ver fahren zu ihrer Herstellung
US4000155A (en) * 1975-12-11 1976-12-28 Eli Lilly And Company Herbicidal 2-methyl-4-phenyl-5-pyrazolinones[and isoxazolinones]
ATE161833T1 (de) * 1992-12-08 1998-01-15 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
ES2185800T3 (es) * 1995-09-15 2003-05-01 Upjohn Co Agentes antibacterianos basados en 5-amidometilo, 3-arilo butirolactona alfa, beta saturada e insaturada.
GB9521508D0 (en) * 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
ES2186916T3 (es) * 1996-08-21 2003-05-16 Upjohn Co Derivados de isoxazolina como agentes antimicrobianos.

Also Published As

Publication number Publication date
AU748750B2 (en) 2002-06-13
TR200100672T2 (tr) 2001-07-23
HUP0103433A3 (en) 2002-08-28
CZ2001669A3 (cs) 2001-08-15
ID27690A (id) 2001-04-19
CO5160266A1 (es) 2002-05-30
EP1107756A4 (en) 2003-02-26
CN1314813A (zh) 2001-09-26
WO2000010566A1 (en) 2000-03-02
NO20010916D0 (no) 2001-02-23
JP2002523369A (ja) 2002-07-30
PE20001063A1 (es) 2000-12-24
AU5783399A (en) 2000-03-14
BR9913225A (pt) 2001-05-22
EP1107756A1 (en) 2001-06-20
TW572757B (en) 2004-01-21
KR20010072945A (ko) 2001-07-31
PL346267A1 (en) 2002-01-28
ZA200101505B (en) 2002-02-22
NZ509867A (en) 2003-08-29
NO20010916L (no) 2001-04-10
IL141542A0 (en) 2002-03-10
UY25677A1 (es) 2001-08-27
CA2341271A1 (en) 2000-03-02
HUP0103433A2 (hu) 2002-01-28

Similar Documents

Publication Publication Date Title
AR020250A1 (es) Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
BR1100336A (pt) Composição farmacêutica para uso oral, e, processo para preparar a mesma
CO5290256A1 (es) Derivados pirazol triciclicos
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
AR026990A1 (es) Antagonistas de neurokinina selectivos
AR064873A2 (es) Compuestos relacionados con inmunoensayo para insecticidas a base de neonicotinilo
AR019790A2 (es) Compuestos derivados de la eritromicina, composiciones que los contienen. uso para preparar un medicamento
ES2133324T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso.
KR900016167A (ko) 아릴-치환된 로다닌 유도체
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
CO5261527A1 (es) Eteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
AR012436A1 (es) Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion.
AR046874A1 (es) Nuevos metodos
CO5601010A2 (es) Derivados de oxazolidinona, procesos para su preparacion y composiciones farmaceuticas que los contienen
AR030868A1 (es) Compuestos de 14-[n-oxicarbonilcarbamato] de mutilina; procedimiento para prepararlos; composiciones farmaceuticas formuladas con dichos compuestos; el uso terapéutico de los mismos y procedimiento de tratamiento de infecciones microbianas administrando dichos compuestos
KR910021364A (ko) 신규 프로판아민, 그의 약리학적 특성 및 치료 목적, 특히 지사제로서의 용도
ES2084120T3 (es) Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina.
AR037140A1 (es) Un compuesto de aminopirrol, su utilizacion, un procedimiento para producirlo y una composicion que lo comprende
ATE340155T1 (de) Medizinische anwendungen von phenylalkanolen und derivaten davon
TH51996B (th) นิวโรคินินแอนทาโกนิสต์ที่เฉพาะเจาะจง
PT94906A (pt) Processo para a preparacao de novos derivados n-(23-vincristinoilicos) e n-(5'-noranidro-23-vinblastinoilicos) do acido 1-amino-metil-fosfonico
EA200400864A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ 2-(4-ЭТОКСИФЕНИЛ)-3-(4-МЕТАНСУЛЬФОНИЛФЕНИЛ)ПИРАЗОЛО[1,5-b]ПИРИДАЗИН В ФОРМЕ НАНОЧАСТИЦ
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion

Legal Events

Date Code Title Description
FA Abandonment or withdrawal